Asma Ravanbakhsh
1, Majid Mahdavi
2*, Ghader Jalilzade-Amin
2, Shahram Javadi
2, Masoud Maham
2, Daryosh Mohammadnejad
3, Mohammad Reza Rashidi
4*1 Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran.
2 Department of Clinical Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran.
3 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
4 School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract
Purpose: Median septum of Juglans regia L. (Juglandaceae) with
anti-diabetic effects has been used in Iranian traditional medicine. The
present study estimates both oral acute and subchronic toxicities.
Methods: In the oral acute toxicity study, female
Wistar rats were treated with doses of 10, 100, 1000, 1600, 2900 and 5000 mg/
kg of the Juglans regia septum of methanol extract (JRSME), and were
monitored for 14 days. In subchronic study, JRSME was administered by gavage at
dose of 1000 mg/kg daily in Wistar rats for 28 days. Antioxidant status and
biochemical examinations were fulfilled, and the vital organs were subjected to
pathological analyses.
Results: The extract did not produce any toxic signs or deaths; the medium
lethal dose must be higher than 5000 mg/kg. In subchronic study, No significant
morphological and histopathological changes were observed in the studied
tissues. There was a significant increase in serum malondialdehyde (MDA) level
in treated group compared to control after 4 weeks of JRSME intake. The
treatment of rats resulted in a significant reduction of serum urea level
(p<0.05), kidney’s xanthine dehydrogenase (XDH) activity (p<0.001) and
elevation of aldehyde oxidase (AO) activity (p<0.05) in kidney. In the
treated group, the mean diameter of glomerulus and proximal urine tube
epithelium stature was slightly greater than control group. A significant
increase in serum MDA level is subject for further studies.
Conclusion: This study showed that the extract has no acute or subacute adverse
effects with dose of 1000 mg/kg. The administration of JRSME may improve kidney
structure and function and help in treatment of some chronic diseases.